| Authors: |
Saha S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Rehman L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Rehman A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Darbaniyan F; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX., Weber DM; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Becnel M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Gaballa M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Chang CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Arora R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Menges M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., Corallo S; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., Davila ML; Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., Peterson C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt and Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., Saini NY; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. |
